The stapler is a device that replaces manual sutures used in surgery and has significant advantages. The number of surgical operations has naturally increased, the penetration rate of staplers has increased, and the promotion of minimally invasive surgery has been superimposed on the rapid growth of the stapler market. In 2019, my country's stapler market is close to 9.5 billion yuan, and has maintained an annual growth rate of 18% in recent years.
Facing the huge “cake” stapler market, what is the current domestic market pattern? What are the driving factors for market development？
Driving factors for market development
First, minimally invasive surgery and intelligent instrument operation are the general trend.
Taking traditional cardiothoracic surgery as an example, thoracotomy has the characteristics of large wounds, more bleeding, and slow recovery, while minimally invasive surgery is assisted by advanced and high-precision surgical instruments to ensure minimal damage to the patient Realize the treatment of the disease under the following conditions, and minimize the trauma of the patient in the treatment process. It can be seen that minimally invasive surgery is bound to become the end point research and development direction of various surgical operations. The proportion of minimally invasive surgery in developed countries has reached 80%-90%, while the proportion of minimally invasive surgery in the best hospitals in China is only 70% to 80%. The proportion in second- and third-tier hospitals is even lower, perhaps even less than 50%. The popularity of minimally invasive surgery will drive the stapler market to continue to grow.
With the development of science and technology in the medical field, the accuracy and safety requirements for surgical operations are getting higher and higher. The intelligent stapler product does not change the doctor's operation method, while bringing convenience to the doctor, eliminating individual differences, and realizing the automation of the operation. In the Western European market, Johnson & Johnson's electric endoscopic stapler exceeds 30%, and it has not been popularized in China. This is still an opportunity for Chinese companies.
Second, the new medical reform encourages general disease operations not to leave the county as much as possible, which will promote an increase in the stapler market in the primary market.
In 2018, the National Health Commission and the State Administration of Traditional Chinese Medicine issued the "Work Plan for Comprehensively Improving the Comprehensive Capability of County-level Hospitals (2018-2020)", which required further improvement of the comprehensive service capabilities of county-level hospitals, and achieved a treatment rate of 90 in the county %. By 2020, 500 county hospitals and county TCM hospitals will reach the service capacity requirements of tertiary hospitals and tertiary TCM hospitals respectively. At the same time, most of the staplers have not been included in the scope of medical insurance reimbursement, and are self-paid products, which inhibits patient use to a certain extent. From this perspective, the penetration rate of staplers in the grassroots market still has a large room for growth.
Third, new opportunities for import substitution.
At present, the entire domestic stapler market is dominated by foreign capital. For example, the volume of imported open staplers exceeds 60%, and the volume of domestic staplers is less than 40%. There are many domestic manufacturers of open staplers and the competition is fierce. In the long run, the domestic stapler industry will be shuffled and the concentration will increase. For endoscope staplers with the broadest market prospects and the highest technical requirements, 90% are basically monopolized by foreign manufacturers (Johnson & Johnson, Medtronic). Domestic manufacturers should actively research and develop and deploy. Manufacturers with first-mover advantages and core technologies will take the lead.
About Surgaid products:
